For patients with symptomatic and severe tricuspid regurgitation (TR), tricuspid transcatheter edge-to-edge repair (T-TEER) ...

For patients with symptomatic and severe or greater tricuspid regurgitation (TR), transcatheter tricuspid valve replacement ...

Transcatheter tricuspid-valve replacement is superior to medical therapy alone for patients with severe tricuspid ...

TUESDAY, Nov. 5, 2024 (HealthDay News) -- For patients with symptomatic and severe or greater tricuspid regurgitation (TR), transcatheter tricuspid valve replacement (TTVR) plus optimal medical ...

Clinical data and machine learning can help to predict intradialytic hypotension (IDH) for patients undergoing hemodialysis, according to a study published online Sept. 14 in the Journal of Kidney ...

Edwards Lifesciences Corp., Orange County’s most valuable publicly traded medical device maker, reported third quarter sales ...

"I was working full-time, running my three kids around at school… I ran businesses," she said. That all came to a head in ...

Edwards Lifesciences Co. (NYSE:EW – Get Free Report) insider Larry L. Wood sold 25,000 shares of Edwards Lifesciences stock ...

When patients were re-classified based on the adjusted thresholds of N-terminal pro-brain natriuretic peptide and 6-minute walk distance and the inclusion of TAPSE rather than right atria area, ...

TRAVEL II study aims to evaluate the long-term safety and efficacy of LuX-Valve Plus in the application on patients with severe tricuspid regurgitation (TR) and high surgical risk. The clinical trial ...